implicity
Request A Demo

Experience the New Standard in AI Remote Cardiac Monitoring

The Implicity platform1 is associated with a 26% reduced mortality and 4% reduction in hospitalization length compared to conventional remote monitoring2.

The AI-Powered Platform for Remote Cardiac Monitoring

Our platform unifies all cardiac device data into a single intelligent system designed for faster decisions and efficient remote monitoring.

Physicians

Focused remote monitoring with fewer false alerts and faster decision-making.

Learn More

Care Teams

Nurses and technicians who need clear alerts and a simple interface to save time.

Learn More

Admin & Billing Teams

Automated billing, higher compliance, and accurate reporting with zero complexity.

Learn More

IT Teams

Ensure data security and compliance, seamless cloud-based updates

Learn More

The key advantages that make our platform smarter, faster, and more efficient.

Our platform is trusted by top cardiac specialists for its simplicity and precision, delivering proven clinical impact2. It centralizes all device data, reduces unnecessary alerts, and helps care teams act faster with confidence.

A smarter, safer way to monitor every patient backed by real-world results and expert validation.

“Implicity stands apart for three key reasons: their FDA clearance, their ability to deliver vast amounts of discrete data, and their sophisticated use of AI. It’s not just about the AI they use today, but how that foundation allows for even greater innovation down the line.”
Manish Wadhwa, MD
SDHV, San Diego

Save time by focusing on meaningful events

Improve patients survival2

Optimize billing compliance4 and maximize revenue

Implicity is a pioneer in SaaS agnostic platforms for CIED remote monitoring equipped with FDA-cleared AI-driven software as a medical device.

Trusted partner logoTrusted partner logoTrusted partner logoTrusted partner logoEIC-logo-CoFundedBy-CMYK_EN

The core technologies that power our platform

Our platform is built on advanced, clinically validated technologies3 that simplify remote monitoring, enhance accuracy, and support faster, more confident decision-making.

ILR ECG Analyzer⁵

ILR ECG Analyzer⁵

Utilize FDA-cleared AI to reduce the number of false positives by 79% when analyzing ECG recordings from patients implanted with Medtronic ILRs, while maintaining a sensitivity of 99%.⁶

Learn more
InLink

InLink

Streamline your In-Clinic data workflow.

Learn more
Patient Connectivity Management

Patient Connectivity Management

Reconnect 28%⁷ of patients two days after they disconnect, using automated SMS.

Learn more
AF Alert Management¹

AF Alert Management¹

Detect clinically relevant events proven to lead to an 85% decrease in unnecessary AF alerts compared to alerts transmitted by a cardiac implantable electronic device (CIED)⁸.

Learn more
Dynamic Billing Engine

Dynamic Billing Engine

Achieve 90%+ billing compliance⁴ with optimized scheduling and auto-generated reports.

SignalHF⁹ Predictive AI

SignalHF⁹ Predictive AI

Cardiac remote monitoring platform with FDA-cleared AI to predict hospitalizations.

Learn more
ISO 13485 quality management for medical devices
MD 687058
ISO 27001 certificationHDS certification
  1. 1IM009 AF Alert Management is a CE marked class I medical device (MDD 93/42/EEC), see the instructions for use for more information. Covered under the conditions defined in Article L. 162-52 of the French Social Security Code.
  2. 2Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.
  3. 3IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information. SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.
  4. 4Jay Ganji, MD, FACC, Cardiologist, Piedmont Cardiovascular, November 2022.
  5. 5IM007 ILR ECG Analyzer is an FDA cleared Class II medical device and CE marked Class I (under MDD) medical device, see the instructions for use for more information.
  6. 6Rosier, Arnaud, et al., A novel machine learning algorithm has the potential to reduce by 1/3 the quantity of ILR episodes needing review, European Heart Journal, Volume 42, Issue Supplement_1, October 2021.
  7. 7Durand, Julien, et al., Using Technology to Improve Reconnection to Remote Monitoring in Cardiac Implantable Electronic Device Patients, Cardiovascular Digital Health Journal, Volume 0, Issue 0 Published: November 23, 2023 DOI.
  8. 8Lazarus, Arnaud, et al. « Filtering of remote monitoring alerts transmitted by cardiac implantable electronic devices and reclassification of atrial fibrillation events by a new algorithm. » Cardiovascular Digital Health Journal 4.5 (2023): 149-154.
  9. 9SignalHF is an FDA-cleared Class II medical device, see the instructions for use for more information. SignalHF is not available for sale in Europe.

The Implicity platform is a clinical decision support device and is in no way intended to replace the responsibility or clinical judgment of the practitioner. It is designed to optimize data workflows and support medical expertise in patient management.

The Smarter Way to Monitor Every Heart.

Smarter monitoring / Cleaner alerts / Faster decisions

Request a Demo